Axillary sentinel lymph node micrometastases with extracapsular extension: a distinct pattern of breast cancer metastasis?

被引:15
作者
Cserni, G. [1 ]
机构
[1] Bacs Kiskun Cty Teaching Hosp, H-6000 Kecskemet, Hungary
关键词
D O I
10.1136/jcp.2007.047357
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To examine the frequency of extracapsular extension (ECE) of sentinel lymph node (SLN) metastases in breast cancer according to metastasis size, and to characterise ECE in micometastases. Methods: If initially negative, SLNs were examined by step-sectioning and immunohistochemistry. Non-SLNs were not subjected to enhanced pathology. Positive axillary SLNs were analysed for metastasis size and the presence of ECE. Results: Of 885 successful SLN biopsy cases, 343 (39%) exhibited SLN involvement, and 115 (34%) displayed ECE. Of the latter, 107 underwent axillary dissection, and 63 (59%) of these demonstrated non-SLN metastases. The presence of ECE correlated with metastasis size (coefficient 0.92). Eight (10%) of the 84 micrometastatic SLN cases had ECE, and two of these were associated with non-SLN metastases. Only ECE and only the intraparenchymal nodal part of the micrometastasis were seen in some sections of five cases each. The primary tumours of the micrometastatic cases with ECE were non-high-grade and often of tubular type. Conclusions: The frequency of ECE increases with increasing nodal metastasis size. Minimal nodal metastases with ECE may represent a distinct pattern of nodal involvement with a predominant capsular and extracapsular, but only minimal or no nodal parenchymal component, predominantly seen in non-poorly differentiated and/or tubular carcinomas. This presentation of nodal metastasis can sometimes pose differential diagnostic problems, and should be distinguished from massive metastases presenting with ECE because it does not seem to be so commonly associated with non-SLN metastases or a massive metastatic load to the axilla as ECE of SLN metastases in general.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 47 条
[1]  
Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO
[2]  
2-B
[3]  
Changsri Channikarn, 2004, Breast J, V10, P392, DOI 10.1111/j.1075-122X.2004.21446.x
[4]   Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting [J].
Cserni, G. ;
Sapino, A. ;
Decker, T. .
BREAST, 2006, 15 (03) :347-354
[5]   The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma [J].
Cserni, G ;
Bianchi, S ;
Vezzosi, V ;
Peterse, H ;
Sapino, A ;
Arisio, R ;
Reiner-Concin, A ;
Regitnig, P ;
Bellocq, JP ;
Marin, C ;
Bori, R ;
Penuela, JM ;
Iturriagagoitia, A .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (05) :518-522
[6]   Improving the reproducibility of diagnosing micrometastases and isolated tumor cells [J].
Cserni, G ;
Bianchi, S ;
Boecker, W ;
Decker, T ;
Lacerda, M ;
Rank, F ;
Wells, CA .
CANCER, 2005, 103 (02) :358-367
[7]   Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer [J].
Cserni, G ;
Burzykowski, T ;
Vinh-Hung, V ;
Kocsis, L ;
Boross, G ;
Sinkó, M ;
Tarján, M ;
Bori, R ;
Rajtár, M ;
Tekle, E ;
Maráz, R ;
Baltás, B ;
Svébis, M .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (09) :519-524
[8]  
Cserni G, 2003, AM SURGEON, V69, P419
[9]   Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two differenct step sectioning and immunohistochemistry protocols in 246 patients [J].
Cserni, G .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (12) :926-931
[10]   Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer [J].
Cserni, G ;
Rajtár, M ;
Boross, G ;
Sinkó, W ;
Svébis, M ;
Baltás, B .
WORLD JOURNAL OF SURGERY, 2002, 26 (05) :592-597